International Stem Cell Corporation Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

International Stem Cell Corporation operates in the biotechnology research sector and is based in San Diego, California. It is developing parthenogenetic stem cells—hpSC—derived from unfertilized human eggs with the aim of creating immune-matched cells for a broad segment of the population, potentially reducing immune rejection in stem cell therapies. The company plans to establish a bank of hpSC lines, called UniStemCell, to serve populations worldwide, and it runs three business lines: Lifeline Cell Technology, Lifeline Skin Care, and Universal Stem Cell Bank.

Its therapeutic focus targets eye, nervous system, and liver diseases where cell therapy has clinical precedent but is limited by the availability of safe, compatible cells. The approach relies on hpSC that do not require viable embryos, addressing certain ethical concerns associated with embryo-derived sources.

Sign up for free to view info

Company overview Employee directory